Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study - Concepedia

Concepedia

Publication | Open Access

Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study

DOI Full Paper Access

156

Citations

15

References

2022

Year

Michael Benatar, Joanne Wuu, Peter M. Andersen, Robert C. Bucelli, Jinsy Andrews, Markus Otto, Nita A. Farahany, Elizabeth A. Harrington, Weiping Chen, Adele A. Mitchell,

Neurotherapeutics

References

	Year	Citations

Page 1